Abstract
Elucidating how molecules bind to HSA is fundamental for predicting drug incompatibilities. Through combinatorial screening, we identified a novel fluorescent dye (BD140) with turn-on fluorescence emission and specific binding at HSA drug site 2. We further combined it with dansylamide to develop a fluorescent dye cocktail for high-throughput mapping of the interaction between therapeutics at HSA drug-binding sites.
Original language | English |
---|---|
Pages (from-to) | 452-457 |
Number of pages | 6 |
Journal | ACS Combinatorial Science |
Volume | 15 |
Issue number | 9 |
DOIs | |
Publication status | Published - Sept 2013 |
Keywords / Materials (for Non-textual outputs)
- drug discovery
- fluorescence
- high-throughput screening human serum albumin
- multiplex assays
- pharmacokinetics
- LIGAND-BINDING PROPERTIES
- BODIPY LIBRARY
- CO-BINDING
- F-19 NMR
- PROBE
- SPECIFICITY
- SENSOR